JanOne Inc. (NASDAQ:JAN – Get Rating)’s share price traded down 1.3% during trading on Tuesday . The stock traded as low as $1.48 and last traded at $1.48. 4,964 shares changed hands during mid-day trading, a decline of 95% from the average session volume of 91,992 shares. The stock had previously closed at $1.50.
JanOne Trading Down 1.3 %
The company has a quick ratio of 0.38, a current ratio of 0.39 and a debt-to-equity ratio of 1.83. The firm has a 50 day moving average of $1.56 and a 200 day moving average of $1.96. The firm has a market cap of $4.66 million, a PE ratio of -0.99 and a beta of 1.91.
Institutional Investors Weigh In On JanOne
A hedge fund recently raised its stake in JanOne stock. Renaissance Technologies LLC grew its stake in shares of JanOne Inc. (NASDAQ:JAN – Get Rating) by 208.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 35,200 shares of the company’s stock after acquiring an additional 23,800 shares during the period. Renaissance Technologies LLC owned 1.12% of JanOne worth $75,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 3.36% of the company’s stock.
About JanOne
JanOne, Inc engages on the development of treatments for diseases that cause severe pain. It operates through the following segments: Biotechnology, Recycling, and Technology. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties.
Featured Stories
- Get a free copy of the StockNews.com research report on JanOne (JAN)
- Under-the-Radar Azul SA Takes Flight on Robust Travel Demand
- Market Gets “Powelled”: S&P 500 Confirms Resistance
- Rivian Plummets, But Is This 2023’s Greatest Buying Opportunity?
- Ulta Insiders Hold Tight: Sell-Siders Buy
- Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy
Receive News & Ratings for JanOne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JanOne and related companies with MarketBeat.com's FREE daily email newsletter.